Abcam
| Formerly |
|
|---|---|
| Company type | Subsidiary |
| Industry | |
| Founded | 1998 |
| Founders |
|
| Headquarters | Cambridge Biomedical Campus, , UK |
Key people | Markus Lusser (president) |
| Products |
|
| Revenue | £361.7 million (2022) |
| £(10.1) million (2022) | |
| £(8.5) million (2022) | |
| Total assets | £1,057 million (2022) |
| Total equity | £726.9 million (2022) |
Number of employees | 1,760 (2022) |
| Parent |
|
| Website | |
Abcam Limited is a producer, distributor and seller of protein research tools operating worldwide from 13 locations with 1,800 employees of which 400 work in Research and Development (R&D). Abcam was listed on the Nasdaq and the London Stock Exchange until it was acquired by Danaher Corporation in 2023.